Trials / Unknown
UnknownNCT03752476
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,300 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the impact of rank of Beta lactam antibiotics on emergence of mutlidrug resistant bacteria colonization in intensive care It's retrospective case controle study. Cases are colonized patient by multidrug resistant bacteria hospitalized in intensive care during the fist hospitalization in intensive care. Temoin are patients with the same characteristics than case but no colonized by multidrug resistant bacteria.
Detailed description
The emergence of multidrug resistant is a wordwide problem. B lactam resistant increase. The antibiotic prescription impact this problem. B lactam antibiotic is prescribed everyday in intensive care unit. The switch of antibiotic is common. Antibiotic classes inclue a lot of rank with different spectum that impact the occurrence of resistant.
Conditions
- Resistant Infection
- Antibiotic Resistant Infection
- Beta Lactam Resistant Bacterial Infection
- Bacterial Resistance
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | number of Beta lactam class prescription for the same infection | Each number of Beta lactam prescription without interruption are compared |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
- First posted
- 2018-11-26
- Last updated
- 2018-11-26
Source: ClinicalTrials.gov record NCT03752476. Inclusion in this directory is not an endorsement.